Photo: Marko Kallio
Health AI, Digital Twins & Chip Twins
– Bridging AI-driven simulations and organ-on-chip models to transform healthcare and drug discovery –
29 October at 10-18 | Tampere University, Kauppi campus, Arvo Ylpön katu 34, Yellow Hall
Ahead of the two-day MET Research Days event, the Industrial Pre-event will focus on data, AI, and digital & chip twins for modeling healthcare processes and cost-effectiveness. This event provides a unique opportunity to connect AI developers with pharma and life science companies, clinicians, and impact researchers, and to explore partnerships for P4 (Predictive, Preventive, Personalized, Participatory) industry consortium projects.
The pre-event is organized by Business Tampere, the Faculty of Medicine and Health Technology, and the Tampere Health Ecosystem – an internationally connected, science-driven community at the forefront of P4 Medicine, leveraging New Approach Methodologies (NAM) and digital twins. The Tampere Health Ecosystem integrates innovative approaches, such as human organ-on-chip models and AI-based simulations, with testbed environments and real-world clinical data. This powerful combination accelerates drug discovery, improves translational relevance, and supports regulatory acceptance on the path to global markets.
Join us to discuss, network, and discover new opportunities at the cutting edge of healthcare and medical research!
Registration
Register by 22 October 2025: Link to the registration page. (deadline extended)
Programme
Spearkers of the event
| 9:30-10:00 | Morning coffee and networking |
| 10:00-12:00 | Health AI & digital twins driving P4 medicine |
| Opening of the event: Seppo Parkkila, Professor, Dean
Introduction of MET research: Minna Kellomäki, Professor, Vice Dean for Research Keynote 1: Miika Leminen, Innovation Director, AI-powered Healthcare and Social Services, CGI – Digital triplets: making digital twins work for healthcare professionals Frank Emmer-Streib, Professor, Tampere University & Pekka Honkanen Chairman of the board, HippocrAItes Oy – Digital twin system as a new paradigm, case diabetes care Juhana Frösén, Professor, Tampere University & Sami Lakka, CEO, Lakka Health Oy – Data-driven personalized and predictive cardiovascular health Timo Erkkilä, CEO, Veracell Oy, Sheikh Jubaer, Tampere University – Digital twins to model healthcare interventions’ cost-effectiveness |
|
| 12:00-13:00 | Lunch |
| 13:00-14:00 | Chip twin for faster and more personalized drug development |
| Keynote 2: Baedr Kayali, General Manager, AbbVie Finland Oy – Pharma powering European innovation and growth
Keynote 3: Antti Nurmi, General Manager, Charles River – Current and future of NAMs in drug development – CRO perspective Paula Puistola, COO, LifeGlue Technologies Oy – Building better tissues: the role of multi-material applications in tissue engineering and regenerative medicine |
|
| 14:00-14:30 | Coffee |
| 14:30-15:00 | Joose Kreutzer, CEO, Biogenium Microsystems Oy – Transforming organ-on-chip research with scalable microenvironment solutions
Heidi Haikala, CSO, Solid IO – Removing guesswork from cancer care with functional tumor-on-chip testing |
| 15:00-15:45 | Panel discussion about future expectations
Moderator: Juhana Frösén, TAU, MET Panelists:
|
| 15:45-18:00 | Snacks and networking |
In collaboration with:
